These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2044501)

  • 21. Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures.
    Devinsky O; Faught RE; Wilder BJ; Kanner AM; Kamin M; Kramer LD; Rosenberg A
    Epilepsy Res; 1995 Mar; 20(3):241-6. PubMed ID: 7796796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Felbamate increases phenytoin but decreases carbamazepine concentrations.
    Fuerst RH; Graves NM; Leppik IE; Brundage RC; Holmes GB; Remmel RP
    Epilepsia; 1988; 29(4):488-91. PubMed ID: 3391153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
    Marciani MG; Spanedda F; Placidi F; Bassetti MA; Romigi A; Mattia D
    Int J Neurosci; 1998 Sep; 95(3-4):247-53. PubMed ID: 9777442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: experience in the United States with three novel drugs.
    French JA
    Epilepsia; 1996; 37 Suppl 2():S23-S26. PubMed ID: 8641243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Felbamate as an add-on therapy for refractory epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008295. PubMed ID: 21249704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Felbamate.
    Pellock JM
    Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of felbamate after kainic acid-induced status epilepticus.
    Chronopoulos A; Stafstrom C; Thurber S; Hyde P; Mikati M; Holmes GL
    Epilepsia; 1993; 34(2):359-66. PubMed ID: 8453945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
    Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felbamate pharmacology and use in epilepsy.
    Burdette DE; Sackellares JC
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats.
    Borowicz KK; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Pharmacol Biochem Behav; 2004 May; 78(1):103-10. PubMed ID: 15159139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome
    N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Felbamate in an adult population with severe refractory epilepsy.
    Kearney H; Delanty N
    Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.